Rule 25 Aug 2025 compliance, environmental regulation, environmental protection, epa, administrative practice and procedure, reporting and recordkeeping requirements, incorporation by reference, intergovernmental relations, ozone, air pollution control, volatile organic compounds, sulfur oxides, emissions control, florida, waste treatment and disposal, aluminum, fluoride, phosphate, fertilizers, solid waste incineration, methane, industrial facilities

♻️Florida Approves Emissions Control Plan for Waste Incineration

The Environmental Protection Agency is taking final action to approve a state plan submitted by the State of Florida, through the Florida Department of Environmental Protection (FDEP) on May 31, 2017, that was supplemented on December 19, 2017, and February 2, 2018, for implementing and enforcing the Emissions Guidelines (EG) applicable to existing Commercial and Industrial Solid Waste Incineration (CISWI) units. The State plan provides for implementation and enforcement of the EG, as finalized by the EPA on February 7, 2013, and amended on June 23, 2016, applicable to existing CISWI units for which construction commenced on or before June 4, 2010, or for which modification or reconstruction commenced after June 4, 2010, but no later than August 7, 2013. The Florida State plan establishes emission limits, monitoring, operating, recordkeeping, and reporting requirements for affected CISWI units.

Learn More
Notice 16 Jun 2025 regulatory compliance, public meeting, fda, prescription drugs, safety concerns, fluoride, pediatric health

🧪FDA Announces Public Meeting on Unapproved Fluoride Prescription Drugs

The Food and Drug Administration (FDA, the Agency, or we) is announcing the following public meeting entitled "Use of Orally Ingestible Unapproved Prescription Drug Products Containing Fluoride in the Pediatric Population." The purpose of the hybrid public meeting is to seek public input on the clinical use and safety concerns associated with the use of orally ingestible unapproved prescription drug products containing fluoride in the pediatric population. The public meeting will be facilitated by the Reagan-Udall Foundation for the FDA. FDA is establishing a docket for public comment on this topic.

Learn More